X

NKCF News

December 2017 Newsletter

In this issue: Eye drop treatment for KC, CXL insurance update, KC & Downsyndrome, plus is there a KC Gene?…

Humans of Keratoconus – Christine

Humans of keratoconus is our patient profile, a way to invite people with keratoconus to share they're KC journey. Christine,…

United Healthcare approves CXL predetermination Appeal

Great news! United Healthcare approves CXL predetermination Appeal! Avedro's Reimbursement Customer Hub (ARCH) has assisted in overturning United Healthcare's initial…

Giving Tuesday

Today is #GivingTuesday! A day of generosity Take a moment during this season of thanks & giving to celebrate with…

Avedro Marks the First Anniversary of Availability of the Only FDA Approved Corneal CrossLinking Treatment in The U.S.

Avedro celebrates their 1 year anniversary of the commercial availability of Photrexa Viscous and Photrexa, drugs used in corneal cross-linking…

Humans of Keratoconus – Amritpal

Humans of keratoconus is our patient profile, a way to invite people with keratoconus to share they're KC journey. Meet…

NKCF in DC!

On November 7, Mary Prudden, Executive Director of NKCF, joined The National Alliance for Eye Research in Washington, DC in…

World KC Day Ambassador Tommy Pham

An extended interview with World KC Day Ambassador, Tommy Pham! Learn more about how living with KC, CXL and Contact…

World KC Day 2017

On November 10th we honor World KC Day, a national awareness day sponsored by NKCF. This day is dedicated to…

May 2017 Newsletter

In this Issue: CXL in Teens & Children, Experts weight in on Epi On vs Epi Off, 2017 Most Voted…